1,2-dichloroethane decreases expression ISO RGD:1622354 6480464 ethylene dichloride results in decreased expression of VEGFB mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1622354 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VEGFB mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:619799 6480464 1-Naphthylisothiocyanate results in increased expression of VEGFB mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO RGD:619799 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of VEGFB mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1622354 6480464 [AHR gene mutant form results in decreased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VEGFB mRNA, [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of VEGFB mRNA CTD PMID:16214954 , PMID:24035824 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:619799 6480464 Tetrachlorodibenzodioxin results in decreased expression of VEGFB mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:619799 6480464 Tetrachlorodibenzodioxin results in increased expression of VEGFB mRNA CTD PMID:24475139 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1622354 6480464 Tetrachlorodibenzodioxin affects the expression of VEGFB mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1622354 6480464 Tetrachlorodibenzodioxin results in increased expression of VEGFB mRNA CTD PMID:12167310 , PMID:19182260 2,4,6-trinitrotoluene affects expression ISO RGD:619799 6480464 Trinitrotoluene affects the expression of VEGFB mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression ISO RGD:619799 6480464 2, 4-dinitrotoluene affects the expression of VEGFB mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1622354 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of VEGFB mRNA CTD PMID:20188158 4-amino-2,6-dinitrotoluene affects expression ISO RGD:619799 6480464 4-amino-2, 6-dinitrotoluene affects the expression of VEGFB mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO RGD:1622354 6480464 Fenretinide results in decreased expression of VEGFB mRNA CTD PMID:28973697 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of VEGFB mRNA CTD PMID:33167477 aluminium oxide increases expression EXP 6480464 Aluminum Oxide results in increased expression of VEGFB mRNA CTD PMID:19464052 ammonium chloride affects expression ISO RGD:619799 6480464 Ammonium Chloride affects the expression of VEGFB mRNA CTD PMID:16483693 antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of VEGFB mRNA CTD PMID:24449571 arsane increases expression EXP 6480464 Arsenic results in increased expression of VEGFB mRNA CTD PMID:11134558 arsane affects expression EXP 6480464 Arsenic affects the expression of VEGFB mRNA, Arsenic affects the expression of VEGFB protein CTD PMID:18414638 , PMID:24675094 arsenic atom affects expression EXP 6480464 Arsenic affects the expression of VEGFB mRNA, Arsenic affects the expression of VEGFB protein CTD PMID:18414638 , PMID:24675094 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of VEGFB mRNA CTD PMID:11134558 arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFB mRNA CTD PMID:29699374 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of VEGFB mRNA CTD PMID:29699374 benzo[a]pyrene decreases expression ISO RGD:1622354 6480464 Benzo(a)pyrene results in decreased expression of VEGFB mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of VEGFB promoter CTD PMID:27901495 bis(2-chloroethyl) sulfide multiple interactions EXP 6480464 IL10 protein affects the reaction [Mustard Gas affects the expression of VEGFB mRNA] CTD PMID:16173061 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1622354 6480464 Diethylhexyl Phthalate results in increased expression of VEGFB mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1622354 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of VEGFB mRNA] CTD PMID:19850644 bisphenol A multiple interactions ISO RGD:619799 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of VEGFB mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:619799 6480464 bisphenol A results in decreased expression of VEGFB mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VEGFB mRNA CTD PMID:29275510 bisphenol A increases methylation ISO RGD:619799 6480464 bisphenol A results in increased methylation of VEGFB gene CTD PMID:28505145 bisphenol A affects expression ISO RGD:619799 6480464 bisphenol A affects the expression of VEGFB mRNA CTD PMID:25181051 bleomycin A2 increases expression ISO RGD:1622354 6480464 Bleomycin results in increased expression of VEGFB protein CTD PMID:30825431 bleomycin A2 multiple interactions ISO RGD:1622354 6480464 Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of VEGFB protein], lenabasum inhibits the reaction [Bleomycin results in increased expression of VEGFB protein] CTD PMID:30825431 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of VEGFB mRNA CTD PMID:17895889 bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of VEGFB mRNA CTD PMID:17659339 C60 fullerene increases expression ISO RGD:619799 6480464 fullerene C60 results in increased expression of VEGFB mRNA CTD PMID:19167457 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of VEGFB mRNA CTD PMID:25596134 cannabidiol affects methylation ISO RGD:619799 6480464 Cannabidiol affects the methylation of VEGFB gene CTD PMID:30521419 cannabidiol multiple interactions ISO RGD:1622354 6480464 Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of VEGFB protein] CTD PMID:30825431 carbon nanotube decreases expression ISO RGD:1622354 6480464 Nanotubes more ... CTD PMID:25620056 chloroacetaldehyde increases expression EXP 6480464 chloroacetaldehyde results in increased expression of VEGFB mRNA CTD PMID:25596134 chlorpromazine increases expression ISO RGD:619799 6480464 Chlorpromazine results in increased expression of VEGFB mRNA CTD PMID:25596134 chlorpyrifos increases methylation ISO RGD:619799 6480464 Chlorpyrifos results in increased methylation of VEGFB gene CTD PMID:32905263 cidofovir anhydrous increases expression EXP 6480464 Cidofovir results in increased expression of VEGFB mRNA CTD PMID:25596134 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of VEGFB mRNA CTD PMID:27392435 clodronic acid decreases expression EXP 6480464 Clodronic Acid results in decreased expression of VEGFB mRNA CTD PMID:25596134 clofibrate increases expression ISO RGD:619799 6480464 Clofibrate results in increased expression of VEGFB mRNA CTD PMID:21318169 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of VEGFB mRNA CTD PMID:22941251 copper atom increases expression ISO RGD:619799 6480464 Copper results in increased expression of VEGFB mRNA CTD PMID:30556269 copper(0) increases expression ISO RGD:619799 6480464 Copper results in increased expression of VEGFB mRNA CTD PMID:30556269 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of VEGFB mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:619799 6480464 Cyclosporine results in increased expression of VEGFB mRNA CTD PMID:25596134 cyclosporin A affects expression EXP 6480464 Cyclosporine affects the expression of VEGFB mRNA CTD PMID:25596134 diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFB mRNA CTD PMID:29699374 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of VEGFB mRNA CTD PMID:29699374 diazinon affects expression ISO RGD:619799 6480464 Diazinon affects the expression of VEGFB mRNA CTD PMID:22546817 dieldrin affects expression ISO RGD:619799 6480464 Dieldrin affects the expression of VEGFB mRNA CTD PMID:22546817 dioxygen increases expression ISO RGD:1622354 6480464 Oxygen deficiency results in increased expression of VEGFB mRNA CTD PMID:24205000 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of VEGFB mRNA CTD PMID:17914565 , PMID:25596134 endosulfan increases expression ISO RGD:619799 6480464 Endosulfan results in increased expression of VEGFB mRNA CTD PMID:29391264 ethanol decreases expression ISO RGD:1622354 6480464 Ethanol results in decreased expression of VEGFB mRNA CTD PMID:22198099 ethanol affects splicing ISO RGD:1622354 6480464 Ethanol affects the splicing of VEGFB mRNA CTD PMID:30319688 fenofibrate increases expression ISO RGD:619799 6480464 Fenofibrate results in increased expression of VEGFB mRNA CTD PMID:17264098 , PMID:25596134 fipronil increases expression ISO RGD:619799 6480464 fipronil results in increased expression of VEGFB mRNA CTD PMID:34044035 folic acid multiple interactions ISO RGD:1622354 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VEGFB mRNA CTD PMID:22206623 furan increases methylation ISO RGD:619799 6480464 furan results in increased methylation of VEGFB gene CTD PMID:22079235 gentamycin increases expression ISO RGD:619799 6480464 Gentamicins results in increased expression of VEGFB mRNA CTD PMID:33387578 hydralazine multiple interactions EXP 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of VEGFB mRNA CTD PMID:17183730 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of VEGFB mRNA CTD PMID:20044591 indole-3-methanol multiple interactions ISO RGD:619799 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VEGFB mRNA CTD PMID:22129741 leflunomide increases expression ISO RGD:619799 6480464 leflunomide results in increased expression of VEGFB mRNA CTD PMID:24136188 metformin increases expression ISO RGD:619799 6480464 Metformin results in increased expression of VEGFB mRNA CTD PMID:25596134 monosodium L-glutamate decreases expression ISO RGD:619799 6480464 Sodium Glutamate results in decreased expression of VEGFB protein CTD PMID:28755050 N-acetyl-L-cysteine multiple interactions ISO RGD:619799 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VEGFB mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO RGD:619799 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VEGFB mRNA, [Mastic Resin co-treated with Diethylnitrosamine] results in decreased expression of VEGFB mRNA CTD PMID:18977376 , PMID:22129741 N-nitrosodiethylamine multiple interactions ISO RGD:1622354 6480464 [troglitazone co-treated with Diethylnitrosamine] results in increased expression of VEGFB mRNA CTD PMID:18597072 N-nitrosodiethylamine increases expression ISO RGD:1622354 6480464 Diethylnitrosamine results in increased expression of VEGFB mRNA CTD PMID:18597072 nickel dichloride affects expression ISO RGD:619799 6480464 nickel chloride affects the expression of VEGFB mRNA CTD PMID:22546817 p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of VEGFB mRNA CTD PMID:26760959 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of VEGFB mRNA CTD PMID:25596134 paracetamol decreases expression ISO RGD:619799 6480464 Acetaminophen results in decreased expression of VEGFB mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of VEGFB mRNA CTD PMID:32790152 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of VEGFB mRNA CTD PMID:32790152 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of VEGFB mRNA CTD PMID:14741686 pioglitazone increases expression EXP 6480464 Pioglitazone results in increased expression of VEGFB mRNA CTD PMID:32589349 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VEGFB mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1622354 6480464 pirinixic acid results in increased expression of VEGFB mRNA CTD PMID:17950772 more ... pirinixic acid multiple interactions ISO RGD:1622354 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of VEGFB mRNA] CTD PMID:17950772 , PMID:20059764 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of VEGFB mRNA CTD PMID:30152185 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of VEGFB mRNA, resveratrol results in increased expression of VEGFB protein CTD PMID:24604347 rotenone increases expression ISO RGD:619799 6480464 Rotenone results in increased expression of VEGFB mRNA CTD PMID:28374803 sildenafil citrate increases expression ISO RGD:619799 6480464 Sildenafil Citrate results in increased expression of VEGFB mRNA CTD PMID:20583517 sulfadimethoxine multiple interactions ISO RGD:619799 6480464 [Complex Mixtures co-treated with Sulfadimethoxine] results in increased expression of VEGFB mRNA CTD PMID:22687987 sulforaphane increases expression ISO RGD:1622354 6480464 sulforaphane results in increased expression of VEGFB mRNA CTD PMID:30529165 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of VEGFB mRNA CTD PMID:31533062 tetrachloromethane affects expression ISO RGD:619799 6480464 Carbon Tetrachloride affects the expression of VEGFB mRNA CTD PMID:12734012 thalidomide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFB mRNA CTD PMID:29699374 thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of VEGFB mRNA CTD PMID:29699374 thimerosal decreases expression EXP 6480464 Thimerosal results in decreased expression of VEGFB mRNA CTD PMID:27188386 thioacetamide decreases expression ISO RGD:619799 6480464 Thioacetamide results in decreased expression of VEGFB mRNA CTD PMID:34492290 troglitazone multiple interactions ISO RGD:1622354 6480464 [troglitazone co-treated with Diethylnitrosamine] results in increased expression of VEGFB mRNA CTD PMID:18597072 urethane decreases expression EXP 6480464 Urethane results in decreased expression of VEGFB mRNA CTD PMID:28818685 valdecoxib increases expression ISO RGD:619799 6480464 valdecoxib results in increased expression of VEGFB mRNA CTD PMID:24136188 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of VEGFB gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1622354 6480464 Valproic Acid affects the expression of VEGFB mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:619799 6480464 Valproic Acid results in increased expression of VEGFB mRNA CTD PMID:21318169 valproic acid multiple interactions EXP 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of VEGFB mRNA CTD PMID:17183730 venlafaxine hydrochloride decreases expression ISO RGD:619799 6480464 Venlafaxine Hydrochloride results in decreased expression of VEGFB mRNA CTD PMID:25423262 Yessotoxin increases expression EXP 6480464 yessotoxin analog results in increased expression of VEGFB mRNA CTD PMID:30679557
